Skip to Main Content

Academia can be an excellent source of novel drug targets and new technologies that can enhance medicinal discovery. Indeed, academic inventors or founders contributed to more than one-quarter of all medicines approved from 2001 through 2019.

Yet many sponsored research collaborations that hope to tap into academia fail. Academic-industry partnerships present a unique set of challenges that require thoughtful setup and dedicated execution from both the company and academic institution.


While there are many important details of a successful biopharma-academia collaboration, I see three key aspects that biopharma companies should take into account in order to increase the probability of a successful endeavor:

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


Create a display name to comment

This name will appear with your comment

There was an error saving your display name. Please check and try again.